16.70
+0.30
+(1.83%)
At close: April 17 at 8:03:52 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | 47.26M | 52.92M | 221.84M | 248.2M |
| Low Estimate | 47M | 52.3M | 204.56M | 225.24M |
| High Estimate | 47.5M | 53.5M | 230M | 260M |
| Year Ago Sales | 43.78M | 48.62M | 203.82M | 221.84M |
| Sales Growth (year/est) | 7.96% | 8.83% | 8.84% | 11.89% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0KD.F | -- | -- | -- | -- |
| S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
| Maintains | Needham: Buy to Buy | 4/8/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 2/13/2025 |
| Maintains | Needham: Buy to Buy | 2/12/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 12/16/2024 |
| Initiated | Cantor Fitzgerald: Overweight | 11/26/2024 |
| Maintains | Craig-Hallum: Buy to Buy | 11/7/2024 |